Saturday, 05 December 2020


AstraZeneca-Takeda to bid for Israeli incubator

12 June 2013 | News | By BioSpectrum Bureau

AstraZeneca, with Takeda, will bid for the incubator tender against a consortium of OrbiMed, and Johnson & Johnson

AstraZeneca, with Takeda, will bid for the incubator tender against a consortium of OrbiMed, and Johnson & Johnson

Singapore: UK pharmaceutical company AstraZeneca is the second bidder for the dedicated biotech incubator being set up by the Chief Scientist's incubator program at the Ministry of the Economy, according to a leading Israeli financial daily report.

The company will bid for the incubator tender against a consortium of OrbiMed venture capital fund and healthcare giant Johnson & Johnson.

The report speculates that in bidding for the incubator, AstraZeneca will team up with Takeda Ventures, the venture capital fund of Japanese drug company Takeda Pharmaceuticals. The tender bid winner will be announced in the coming few months.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account